National Clinical Trial Launches, Will Test Promising Vaccine Against Novel Coronavirus
Health & BehaviorUC San Diego Health and the Altman Clinical and Translational Research Institute will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the coronavirus that causes COVID-19.